In case you missed it: August 8 to August 12
A look back at the week's top stories.
Vivjoa approved for recurrent vulvovaginal candidiasis
Oteseconazole is a treatment option for those living with a previously unmet medical need.
Essentials of vulvovaginal dermatology
Correct terms and education can help normalize the conversation for patients.
Neighborhood disadvantage and fertility rates
Residing in a socioeconomically disadvantaged neighborhood was linked to moderately decreased fecundability, according to a study published in JAMA Network Open.
Maternal mortality before and during COVID pandemic
Maternal deaths in the United States rose by a staggering 33% after the onset of the COVID-19 pandemic in March 2020, which is a significantly higher percentage than the 22% overall excess death estimate linked to the pandemic, according to a research letter published in JAMA Network Open.
Monkeypox vaccine gets emergency approval to increase vaccine supply
Smaller dose given by intradermal injection creates five-fold increase in total supply, FDA says.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
